A detailed history of State Street Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, State Street Corp holds 8,210,058 shares of EXAS stock, worth $558 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,210,058
Previous 5,093,647 61.18%
Holding current value
$558 Million
Previous $352 Million 1.39%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $129 Million - $231 Million
3,116,411 Added 61.18%
8,210,058 $347 Million
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $4.1 Million - $5.38 Million
72,905 Added 1.45%
5,093,647 $352 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $30.1 Million - $38.6 Million
510,139 Added 11.31%
5,020,742 $371 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $9.02 Million - $13.5 Million
136,796 Added 3.13%
4,510,603 $308 Million
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $11.5 Million - $17.5 Million
-183,710 Reduced 4.03%
4,373,807 $411 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $29.3 Million - $44 Million
-621,286 Reduced 12.0%
4,557,517 $309 Million
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $4.61 Million - $8.08 Million
-151,946 Reduced 2.85%
5,178,803 $256 Million
Q3 2022

Nov 15, 2022

BUY
$31.97 - $49.37 $3.65 Million - $5.63 Million
114,054 Added 2.19%
5,330,749 $173 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $25.6 Million - $54.8 Million
718,536 Added 15.97%
5,216,695 $205 Million
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $14.2 Million - $20.4 Million
247,246 Added 5.82%
4,498,159 $315 Million
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $13.2 Million - $18.3 Million
181,599 Added 4.46%
4,250,913 $331 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $17.7 Million - $24.4 Million
196,624 Added 5.08%
4,069,314 $388 Million
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $49.8 Million - $74.1 Million
532,211 Added 15.93%
3,872,690 $481 Million
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $14.2 Million - $18.9 Million
-121,659 Reduced 3.51%
3,340,479 $440 Million
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $15.6 Million - $22.3 Million
-156,674 Reduced 4.33%
3,462,138 $459 Million
Q3 2020

Nov 10, 2020

BUY
$72.92 - $102.01 $667,145 - $933,289
9,149 Added 0.25%
3,618,812 $369 Million
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $12.9 Million - $21.4 Million
-231,127 Reduced 6.02%
3,609,663 $314 Million
Q1 2020

May 11, 2020

BUY
$37.9 - $104.44 $146 Million - $401 Million
3,840,790 New
3,840,790 $223 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.